Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease
- PMID: 30183251
- DOI: 10.1021/acschemneuro.8b00288
Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease
Abstract
Parkinson's disease is pathologically characterized by the degeneration of dopaminergic neurons in the substantia nigra and the accumulation of neuronal cytoplasmic inclusions known as Lewy bodies, which are primarily composed of α-synuclein. Post-translational modifications of α-synuclein induced by nitrative stress have been linked to neurodegeneration. Here, we review the concept of α-synuclein nitration and its biological consequences. We also discuss the pathological roles of nitrated α-synuclein and their potential clinical implications in Parkinson's disease.
Keywords: Parkinson’s disease; nitration; α-synuclein.
Similar articles
-
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10. Brain. 2010. PMID: 19903734
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts.Biomolecules. 2020 Mar 3;10(3):391. doi: 10.3390/biom10030391. Biomolecules. 2020. PMID: 32138193 Free PMC article. Review.
-
Initiation and propagation of α-synuclein aggregation in the nervous system.Mol Neurodegener. 2020 Mar 6;15(1):19. doi: 10.1186/s13024-020-00368-6. Mol Neurodegener. 2020. PMID: 32143659 Free PMC article. Review.
-
Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?Biomolecules. 2015 Jul 16;5(3):1467-79. doi: 10.3390/biom5031467. Biomolecules. 2015. PMID: 26193328 Free PMC article. Review.
Cited by
-
SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models.EMBO Mol Med. 2021 Apr 9;13(4):e13076. doi: 10.15252/emmm.202013076. Epub 2021 Mar 1. EMBO Mol Med. 2021. PMID: 33646633 Free PMC article.
-
Posttranslational Modifications of α-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111. Pharmacol Rev. 2024. PMID: 39164116 Free PMC article. Review.
-
Age-related nitration/dysfunction of myogenic stem cell activator HGF.Aging Cell. 2024 Feb;23(2):e14041. doi: 10.1111/acel.14041. Epub 2023 Nov 20. Aging Cell. 2024. PMID: 37985931 Free PMC article.
-
Narrative Review Concerning the Clinical Spectrum of Ophthalmological Impairments in Parkinson's Disease.Neurol Int. 2023 Jan 26;15(1):140-161. doi: 10.3390/neurolint15010012. Neurol Int. 2023. PMID: 36810467 Free PMC article. Review.
-
Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.Glycoconj J. 2022 Feb;39(1):55-74. doi: 10.1007/s10719-021-10024-w. Epub 2021 Nov 10. Glycoconj J. 2022. PMID: 34757539 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical